Search

Your search keyword '"Williams, P. Mickey"' showing total 64 results
Start Over Author "Williams, P. Mickey" Publisher american association for cancer research (aacr)
64 results on '"Williams, P. Mickey"'

1. Supplementary Figures 1 from Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI–MATCH ECOG–ACRIN Trial (EAY131) Subprotocol J

Author

Connolly, Roisin M., primary, Wang, Victoria, primary, Hyman, David M., primary, Grivas, Petros, primary, Mitchell, Edith P., primary, Wright, John J., primary, Sharon, Elad, primary, Gray, Robert J., primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David R., primary, Williams, P. Mickey, primary, Hamilton, Stanley R., primary, Wang, Jue, primary, Wisinski, Kari B., primary, Tricoli, James V., primary, Conley, Barbara A., primary, Harris, Lyndsay N., primary, Arteaga, Carlos L., primary, O'Dwyer, Peter J., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2024
Full Text
View/download PDF

2. Supplementary tables 1 from Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI–MATCH ECOG–ACRIN Trial (EAY131) Subprotocol J

Author

Connolly, Roisin M., primary, Wang, Victoria, primary, Hyman, David M., primary, Grivas, Petros, primary, Mitchell, Edith P., primary, Wright, John J., primary, Sharon, Elad, primary, Gray, Robert J., primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David R., primary, Williams, P. Mickey, primary, Hamilton, Stanley R., primary, Wang, Jue, primary, Wisinski, Kari B., primary, Tricoli, James V., primary, Conley, Barbara A., primary, Harris, Lyndsay N., primary, Arteaga, Carlos L., primary, O'Dwyer, Peter J., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2024
Full Text
View/download PDF

3. Data from Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI–MATCH ECOG–ACRIN Trial (EAY131) Subprotocol J

Author

Connolly, Roisin M., primary, Wang, Victoria, primary, Hyman, David M., primary, Grivas, Petros, primary, Mitchell, Edith P., primary, Wright, John J., primary, Sharon, Elad, primary, Gray, Robert J., primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David R., primary, Williams, P. Mickey, primary, Hamilton, Stanley R., primary, Wang, Jue, primary, Wisinski, Kari B., primary, Tricoli, James V., primary, Conley, Barbara A., primary, Harris, Lyndsay N., primary, Arteaga, Carlos L., primary, O'Dwyer, Peter J., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2024
Full Text
View/download PDF

4. Supplementary tables 1 from Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI–MATCH ECOG–ACRIN Trial (EAY131) Subprotocol J

Author

Connolly, Roisin M., primary, Wang, Victoria, primary, Hyman, David M., primary, Grivas, Petros, primary, Mitchell, Edith P., primary, Wright, John J., primary, Sharon, Elad, primary, Gray, Robert J., primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David R., primary, Williams, P. Mickey, primary, Hamilton, Stanley R., primary, Wang, Jue, primary, Wisinski, Kari B., primary, Tricoli, James V., primary, Conley, Barbara A., primary, Harris, Lyndsay N., primary, Arteaga, Carlos L., primary, O'Dwyer, Peter J., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2024
Full Text
View/download PDF

5. Data from Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI–MATCH ECOG–ACRIN Trial (EAY131) Subprotocol J

Author

Connolly, Roisin M., primary, Wang, Victoria, primary, Hyman, David M., primary, Grivas, Petros, primary, Mitchell, Edith P., primary, Wright, John J., primary, Sharon, Elad, primary, Gray, Robert J., primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David R., primary, Williams, P. Mickey, primary, Hamilton, Stanley R., primary, Wang, Jue, primary, Wisinski, Kari B., primary, Tricoli, James V., primary, Conley, Barbara A., primary, Harris, Lyndsay N., primary, Arteaga, Carlos L., primary, O'Dwyer, Peter J., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2024
Full Text
View/download PDF

6. Supplementary Figures 1 from Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI–MATCH ECOG–ACRIN Trial (EAY131) Subprotocol J

Author

Connolly, Roisin M., primary, Wang, Victoria, primary, Hyman, David M., primary, Grivas, Petros, primary, Mitchell, Edith P., primary, Wright, John J., primary, Sharon, Elad, primary, Gray, Robert J., primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David R., primary, Williams, P. Mickey, primary, Hamilton, Stanley R., primary, Wang, Jue, primary, Wisinski, Kari B., primary, Tricoli, James V., primary, Conley, Barbara A., primary, Harris, Lyndsay N., primary, Arteaga, Carlos L., primary, O'Dwyer, Peter J., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2024
Full Text
View/download PDF

7. Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI–MATCH ECOG–ACRIN Trial (EAY131) Subprotocol J

Author

Connolly, Roisin M., primary, Wang, Victoria, additional, Hyman, David M., additional, Grivas, Petros, additional, Mitchell, Edith P., additional, Wright, John J., additional, Sharon, Elad, additional, Gray, Robert J., additional, McShane, Lisa M., additional, Rubinstein, Larry V., additional, Patton, David R., additional, Williams, P. Mickey, additional, Hamilton, Stanley R., additional, Wang, Jue, additional, Wisinski, Kari B., additional, Tricoli, James V., additional, Conley, Barbara A., additional, Harris, Lyndsay N., additional, Arteaga, Carlos L., additional, O'Dwyer, Peter J., additional, Chen, Alice P., additional, and Flaherty, Keith T., additional

Published
2024
Full Text
View/download PDF

8. Data from Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B

Author

Clark, Amy S., primary, Hong, Fangxin, primary, Finn, Richard S., primary, DeMichele, Angela M., primary, Mitchell, Edith P., primary, Zwiebel, James, primary, Arnaldez, Fernanda I., primary, Gray, Robert J., primary, Wang, Victoria, primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David, primary, Williams, P. Mickey, primary, Hamilton, Stanley R., primary, Copur, Mehmet S., primary, Kasbari, Samer S., primary, Thind, Ravneet, primary, Conley, Barbara A., primary, Arteaga, Carlos L., primary, O'Dwyer, Peter J., primary, Harris, Lyndsay N., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2023
Full Text
View/download PDF

9. Supplementary Table S1 from Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B

Author

Clark, Amy S., primary, Hong, Fangxin, primary, Finn, Richard S., primary, DeMichele, Angela M., primary, Mitchell, Edith P., primary, Zwiebel, James, primary, Arnaldez, Fernanda I., primary, Gray, Robert J., primary, Wang, Victoria, primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David, primary, Williams, P. Mickey, primary, Hamilton, Stanley R., primary, Copur, Mehmet S., primary, Kasbari, Samer S., primary, Thind, Ravneet, primary, Conley, Barbara A., primary, Arteaga, Carlos L., primary, O'Dwyer, Peter J., primary, Harris, Lyndsay N., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2023
Full Text
View/download PDF

10. Data from Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B

Author

Clark, Amy S., primary, Hong, Fangxin, primary, Finn, Richard S., primary, DeMichele, Angela M., primary, Mitchell, Edith P., primary, Zwiebel, James, primary, Arnaldez, Fernanda I., primary, Gray, Robert J., primary, Wang, Victoria, primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David, primary, Williams, P. Mickey, primary, Hamilton, Stanley R., primary, Copur, Mehmet S., primary, Kasbari, Samer S., primary, Thind, Ravneet, primary, Conley, Barbara A., primary, Arteaga, Carlos L., primary, O'Dwyer, Peter J., primary, Harris, Lyndsay N., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2023
Full Text
View/download PDF

11. Supplementary Table S1 from Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B

Author

Clark, Amy S., primary, Hong, Fangxin, primary, Finn, Richard S., primary, DeMichele, Angela M., primary, Mitchell, Edith P., primary, Zwiebel, James, primary, Arnaldez, Fernanda I., primary, Gray, Robert J., primary, Wang, Victoria, primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David, primary, Williams, P. Mickey, primary, Hamilton, Stanley R., primary, Copur, Mehmet S., primary, Kasbari, Samer S., primary, Thind, Ravneet, primary, Conley, Barbara A., primary, Arteaga, Carlos L., primary, O'Dwyer, Peter J., primary, Harris, Lyndsay N., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2023
Full Text
View/download PDF

12. Abstract 6072: Chromosomal aneuploidy, whole-genome doubling and mutational signatures in NCI PDMR models

Author

Chen, Li, primary, Das, Biswajit, additional, Chang, Ting-Chia, additional, Evrard, Yvonne A., additional, Karlovich, Chris A., additional, Chapman, Alyssa, additional, Fullmer, Brandie, additional, Hayes, Ashley, additional, Thornton, Ruth, additional, Nair, Nikitha, additional, Jiwani, Shahanawaz, additional, Dutko, Lindsay, additional, Benauer, Kelly, additional, Rivera, Gloryvee, additional, Camalier, Corinne, additional, Carter, John, additional, Borgel, Suzanne, additional, Miner, Tiffanie, additional, McGlynn, Chelsea, additional, Mills, Justine, additional, Uzelac, Shannon, additional, Shearer, Tia, additional, Hicks, Lauren, additional, Norris, Michelle, additional, Border, Carley, additional, Alcoser, Sergio, additional, Walsh, Thomas, additional, Mullendore, Michael, additional, Eugeni, Michelle, additional, Newton, Dianne, additional, Hollingshead, Melinda G., additional, Williams, P. Mickey, additional, and Doroshow, James H., additional

Published
2023
Full Text
View/download PDF

13. Data from Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B

Author

Clark, Amy S., primary, Hong, Fangxin, primary, Finn, Richard S., primary, DeMichele, Angela M., primary, Mitchell, Edith P., primary, Zwiebel, James, primary, Arnaldez, Fernanda I., primary, Gray, Robert J., primary, Wang, Victoria, primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David, primary, Williams, P. Mickey, primary, Hamilton, Stanley R., primary, Copur, Mehmet S., primary, Kasbari, Samer S., primary, Thind, Ravneet, primary, Conley, Barbara A., primary, Arteaga, Carlos L., primary, O'Dwyer, Peter J., primary, Harris, Lyndsay N., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2023
Full Text
View/download PDF

14. Supplementary Table S1 from Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B

Author

Clark, Amy S., primary, Hong, Fangxin, primary, Finn, Richard S., primary, DeMichele, Angela M., primary, Mitchell, Edith P., primary, Zwiebel, James, primary, Arnaldez, Fernanda I., primary, Gray, Robert J., primary, Wang, Victoria, primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David, primary, Williams, P. Mickey, primary, Hamilton, Stanley R., primary, Copur, Mehmet S., primary, Kasbari, Samer S., primary, Thind, Ravneet, primary, Conley, Barbara A., primary, Arteaga, Carlos L., primary, O'Dwyer, Peter J., primary, Harris, Lyndsay N., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2023
Full Text
View/download PDF

15. Supplementary Table S1 from Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B

Author

Clark, Amy S., primary, Hong, Fangxin, primary, Finn, Richard S., primary, DeMichele, Angela M., primary, Mitchell, Edith P., primary, Zwiebel, James, primary, Arnaldez, Fernanda I., primary, Gray, Robert J., primary, Wang, Victoria, primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David, primary, Williams, P. Mickey, primary, Hamilton, Stanley R., primary, Copur, Mehmet S., primary, Kasbari, Samer S., primary, Thind, Ravneet, primary, Conley, Barbara A., primary, Arteaga, Carlos L., primary, O'Dwyer, Peter J., primary, Harris, Lyndsay N., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2023
Full Text
View/download PDF

16. Supplementary Table 1 from A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Author

Czuczman, Myron S., primary, Trněný, Marek, primary, Davies, Andrew, primary, Rule, Simon, primary, Linton, Kim M., primary, Wagner-Johnston, Nina, primary, Gascoyne, Randy D., primary, Slack, Graham W., primary, Brousset, Pierre, primary, Eberhard, David A., primary, Hernandez-Ilizaliturri, Francisco J., primary, Salles, Gilles, primary, Witzig, Thomas E., primary, Zinzani, Pier Luigi, primary, Wright, George W., primary, Staudt, Louis M., primary, Yang, Yandan, primary, Williams, P. Mickey, primary, Lih, Chih-Jian, primary, Russo, Jacqueline, primary, Thakurta, Anjan, primary, Hagner, Patrick, primary, Fustier, Pierre, primary, Song, Dale, primary, and Lewis, Ian D., primary

Published
2023
Full Text
View/download PDF

17. Supplementary Table 2 from A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Author

Czuczman, Myron S., primary, Trněný, Marek, primary, Davies, Andrew, primary, Rule, Simon, primary, Linton, Kim M., primary, Wagner-Johnston, Nina, primary, Gascoyne, Randy D., primary, Slack, Graham W., primary, Brousset, Pierre, primary, Eberhard, David A., primary, Hernandez-Ilizaliturri, Francisco J., primary, Salles, Gilles, primary, Witzig, Thomas E., primary, Zinzani, Pier Luigi, primary, Wright, George W., primary, Staudt, Louis M., primary, Yang, Yandan, primary, Williams, P. Mickey, primary, Lih, Chih-Jian, primary, Russo, Jacqueline, primary, Thakurta, Anjan, primary, Hagner, Patrick, primary, Fustier, Pierre, primary, Song, Dale, primary, and Lewis, Ian D., primary

Published
2023
Full Text
View/download PDF

18. Supplementary Data from Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131)

Author

Johnson, Douglas B., primary, Zhao, Fengmin, primary, Noel, Marcus, primary, Riely, Gregory J., primary, Mitchell, Edith P., primary, Wright, John J., primary, Chen, Helen X., primary, Gray, Robert J., primary, Li, Shuli, primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David, primary, Williams, P. Mickey, primary, Hamilton, Stanly R., primary, Conley, Barbara A., primary, Arteaga, Carlos L., primary, Harris, Lyndsay N., primary, O'Dwyer, Peter J., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2023
Full Text
View/download PDF

19. Supplementary Data from Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131)

Author

Johnson, Douglas B., primary, Zhao, Fengmin, primary, Noel, Marcus, primary, Riely, Gregory J., primary, Mitchell, Edith P., primary, Wright, John J., primary, Chen, Helen X., primary, Gray, Robert J., primary, Li, Shuli, primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David, primary, Williams, P. Mickey, primary, Hamilton, Stanly R., primary, Conley, Barbara A., primary, Arteaga, Carlos L., primary, Harris, Lyndsay N., primary, O'Dwyer, Peter J., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2023
Full Text
View/download PDF

20. Supplementary Data from Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131)

Author

Johnson, Douglas B., primary, Zhao, Fengmin, primary, Noel, Marcus, primary, Riely, Gregory J., primary, Mitchell, Edith P., primary, Wright, John J., primary, Chen, Helen X., primary, Gray, Robert J., primary, Li, Shuli, primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David, primary, Williams, P. Mickey, primary, Hamilton, Stanly R., primary, Conley, Barbara A., primary, Arteaga, Carlos L., primary, Harris, Lyndsay N., primary, O'Dwyer, Peter J., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2023
Full Text
View/download PDF

21. Supplementary Expression Data from Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer

Author

Kummar, Shivaani, primary, Oza, Amit M., primary, Fleming, Gini F., primary, Sullivan, Daniel M., primary, Gandara, David R., primary, Naughton, Michael J., primary, Villalona-Calero, Miguel A., primary, Morgan, Robert J., primary, Szabo, Peter M., primary, Youn, Ahrim, primary, Chen, Alice P., primary, Ji, Jiuping, primary, Allen, Deborah E., primary, Lih, Chih-Jian, primary, Mehaffey, Michele G., primary, Walsh, William D., primary, McGregor, Paul M., primary, Steinberg, Seth M., primary, Williams, P. Mickey, primary, Kinders, Robert J., primary, Conley, Barbara A., primary, Simon, Richard M., primary, and Doroshow, James H., primary

Published
2023
Full Text
View/download PDF

22. Figure S3 from Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer

Author

Kummar, Shivaani, primary, Oza, Amit M., primary, Fleming, Gini F., primary, Sullivan, Daniel M., primary, Gandara, David R., primary, Naughton, Michael J., primary, Villalona-Calero, Miguel A., primary, Morgan, Robert J., primary, Szabo, Peter M., primary, Youn, Ahrim, primary, Chen, Alice P., primary, Ji, Jiuping, primary, Allen, Deborah E., primary, Lih, Chih-Jian, primary, Mehaffey, Michele G., primary, Walsh, William D., primary, McGregor, Paul M., primary, Steinberg, Seth M., primary, Williams, P. Mickey, primary, Kinders, Robert J., primary, Conley, Barbara A., primary, Simon, Richard M., primary, and Doroshow, James H., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Tables 1-4 from Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131)

Author

Johnson, Douglas B., primary, Zhao, Fengmin, primary, Noel, Marcus, primary, Riely, Gregory J., primary, Mitchell, Edith P., primary, Wright, John J., primary, Chen, Helen X., primary, Gray, Robert J., primary, Li, Shuli, primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David, primary, Williams, P. Mickey, primary, Hamilton, Stanly R., primary, Conley, Barbara A., primary, Arteaga, Carlos L., primary, Harris, Lyndsay N., primary, O'Dwyer, Peter J., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2023
Full Text
View/download PDF

24. Supplementary Table 3 from A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Author

Czuczman, Myron S., primary, Trněný, Marek, primary, Davies, Andrew, primary, Rule, Simon, primary, Linton, Kim M., primary, Wagner-Johnston, Nina, primary, Gascoyne, Randy D., primary, Slack, Graham W., primary, Brousset, Pierre, primary, Eberhard, David A., primary, Hernandez-Ilizaliturri, Francisco J., primary, Salles, Gilles, primary, Witzig, Thomas E., primary, Zinzani, Pier Luigi, primary, Wright, George W., primary, Staudt, Louis M., primary, Yang, Yandan, primary, Williams, P. Mickey, primary, Lih, Chih-Jian, primary, Russo, Jacqueline, primary, Thakurta, Anjan, primary, Hagner, Patrick, primary, Fustier, Pierre, primary, Song, Dale, primary, and Lewis, Ian D., primary

Published
2023
Full Text
View/download PDF

25. Supplementary Data from Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131)

Author

Johnson, Douglas B., primary, Zhao, Fengmin, primary, Noel, Marcus, primary, Riely, Gregory J., primary, Mitchell, Edith P., primary, Wright, John J., primary, Chen, Helen X., primary, Gray, Robert J., primary, Li, Shuli, primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David, primary, Williams, P. Mickey, primary, Hamilton, Stanly R., primary, Conley, Barbara A., primary, Arteaga, Carlos L., primary, Harris, Lyndsay N., primary, O'Dwyer, Peter J., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2023
Full Text
View/download PDF

26. Supplementary Methods, Tables S1 and S2, Figure Legend from Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer

Author

Kummar, Shivaani, primary, Oza, Amit M., primary, Fleming, Gini F., primary, Sullivan, Daniel M., primary, Gandara, David R., primary, Naughton, Michael J., primary, Villalona-Calero, Miguel A., primary, Morgan, Robert J., primary, Szabo, Peter M., primary, Youn, Ahrim, primary, Chen, Alice P., primary, Ji, Jiuping, primary, Allen, Deborah E., primary, Lih, Chih-Jian, primary, Mehaffey, Michele G., primary, Walsh, William D., primary, McGregor, Paul M., primary, Steinberg, Seth M., primary, Williams, P. Mickey, primary, Kinders, Robert J., primary, Conley, Barbara A., primary, Simon, Richard M., primary, and Doroshow, James H., primary

Published
2023
Full Text
View/download PDF

27. Supplementary Data from Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131)

Author

Johnson, Douglas B., primary, Zhao, Fengmin, primary, Noel, Marcus, primary, Riely, Gregory J., primary, Mitchell, Edith P., primary, Wright, John J., primary, Chen, Helen X., primary, Gray, Robert J., primary, Li, Shuli, primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David, primary, Williams, P. Mickey, primary, Hamilton, Stanly R., primary, Conley, Barbara A., primary, Arteaga, Carlos L., primary, Harris, Lyndsay N., primary, O'Dwyer, Peter J., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2023
Full Text
View/download PDF

28. Supplementary Figure Legend from Differential Outcomes in Codon 12/13 and Codon 61 NRAS-Mutated Cancers in the Phase II NCI-MATCH Trial of Binimetinib in Patients with NRAS-Mutated Tumors

Author

Cleary, James M., primary, Wang, Victoria, primary, Heist, Rebecca S., primary, Kopetz, E. Scott, primary, Mitchell, Edith P., primary, Zwiebel, James A., primary, Kapner, Kevin S., primary, Chen, Helen X., primary, Li, Shuli, primary, Gray, Robert J., primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David R., primary, Meric-Bernstam, Funda, primary, Dillmon, Melissa S., primary, Williams, P. Mickey, primary, Hamilton, Stanley R., primary, Conley, Barbara A., primary, Aguirre, Andrew J., primary, O'Dwyer, Peter J., primary, Harris, Lyndsay N., primary, Arteaga, Carlos L., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2023
Full Text
View/download PDF

29. Supplementary Data from Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131)

Author

Johnson, Douglas B., primary, Zhao, Fengmin, primary, Noel, Marcus, primary, Riely, Gregory J., primary, Mitchell, Edith P., primary, Wright, John J., primary, Chen, Helen X., primary, Gray, Robert J., primary, Li, Shuli, primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David, primary, Williams, P. Mickey, primary, Hamilton, Stanly R., primary, Conley, Barbara A., primary, Arteaga, Carlos L., primary, Harris, Lyndsay N., primary, O'Dwyer, Peter J., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2023
Full Text
View/download PDF

30. Supplementary Data from Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131)

Author

Johnson, Douglas B., primary, Zhao, Fengmin, primary, Noel, Marcus, primary, Riely, Gregory J., primary, Mitchell, Edith P., primary, Wright, John J., primary, Chen, Helen X., primary, Gray, Robert J., primary, Li, Shuli, primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David, primary, Williams, P. Mickey, primary, Hamilton, Stanly R., primary, Conley, Barbara A., primary, Arteaga, Carlos L., primary, Harris, Lyndsay N., primary, O'Dwyer, Peter J., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2023
Full Text
View/download PDF

31. Supplemental Figures from Differential Outcomes in Codon 12/13 and Codon 61 NRAS-Mutated Cancers in the Phase II NCI-MATCH Trial of Binimetinib in Patients with NRAS-Mutated Tumors

Author

Cleary, James M., primary, Wang, Victoria, primary, Heist, Rebecca S., primary, Kopetz, E. Scott, primary, Mitchell, Edith P., primary, Zwiebel, James A., primary, Kapner, Kevin S., primary, Chen, Helen X., primary, Li, Shuli, primary, Gray, Robert J., primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David R., primary, Meric-Bernstam, Funda, primary, Dillmon, Melissa S., primary, Williams, P. Mickey, primary, Hamilton, Stanley R., primary, Conley, Barbara A., primary, Aguirre, Andrew J., primary, O'Dwyer, Peter J., primary, Harris, Lyndsay N., primary, Arteaga, Carlos L., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2023
Full Text
View/download PDF

32. Figure S2 from Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer

Author

Kummar, Shivaani, primary, Oza, Amit M., primary, Fleming, Gini F., primary, Sullivan, Daniel M., primary, Gandara, David R., primary, Naughton, Michael J., primary, Villalona-Calero, Miguel A., primary, Morgan, Robert J., primary, Szabo, Peter M., primary, Youn, Ahrim, primary, Chen, Alice P., primary, Ji, Jiuping, primary, Allen, Deborah E., primary, Lih, Chih-Jian, primary, Mehaffey, Michele G., primary, Walsh, William D., primary, McGregor, Paul M., primary, Steinberg, Seth M., primary, Williams, P. Mickey, primary, Kinders, Robert J., primary, Conley, Barbara A., primary, Simon, Richard M., primary, and Doroshow, James H., primary

Published
2023
Full Text
View/download PDF

33. Figure S1 from Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer

Author

Kummar, Shivaani, primary, Oza, Amit M., primary, Fleming, Gini F., primary, Sullivan, Daniel M., primary, Gandara, David R., primary, Naughton, Michael J., primary, Villalona-Calero, Miguel A., primary, Morgan, Robert J., primary, Szabo, Peter M., primary, Youn, Ahrim, primary, Chen, Alice P., primary, Ji, Jiuping, primary, Allen, Deborah E., primary, Lih, Chih-Jian, primary, Mehaffey, Michele G., primary, Walsh, William D., primary, McGregor, Paul M., primary, Steinberg, Seth M., primary, Williams, P. Mickey, primary, Kinders, Robert J., primary, Conley, Barbara A., primary, Simon, Richard M., primary, and Doroshow, James H., primary

Published
2023
Full Text
View/download PDF

34. Supplementary Table 1 from A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Author

Czuczman, Myron S., primary, Trněný, Marek, primary, Davies, Andrew, primary, Rule, Simon, primary, Linton, Kim M., primary, Wagner-Johnston, Nina, primary, Gascoyne, Randy D., primary, Slack, Graham W., primary, Brousset, Pierre, primary, Eberhard, David A., primary, Hernandez-Ilizaliturri, Francisco J., primary, Salles, Gilles, primary, Witzig, Thomas E., primary, Zinzani, Pier Luigi, primary, Wright, George W., primary, Staudt, Louis M., primary, Yang, Yandan, primary, Williams, P. Mickey, primary, Lih, Chih-Jian, primary, Russo, Jacqueline, primary, Thakurta, Anjan, primary, Hagner, Patrick, primary, Fustier, Pierre, primary, Song, Dale, primary, and Lewis, Ian D., primary

Published
2023
Full Text
View/download PDF

35. Figure S3 from Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer

Author

Kummar, Shivaani, primary, Oza, Amit M., primary, Fleming, Gini F., primary, Sullivan, Daniel M., primary, Gandara, David R., primary, Naughton, Michael J., primary, Villalona-Calero, Miguel A., primary, Morgan, Robert J., primary, Szabo, Peter M., primary, Youn, Ahrim, primary, Chen, Alice P., primary, Ji, Jiuping, primary, Allen, Deborah E., primary, Lih, Chih-Jian, primary, Mehaffey, Michele G., primary, Walsh, William D., primary, McGregor, Paul M., primary, Steinberg, Seth M., primary, Williams, P. Mickey, primary, Kinders, Robert J., primary, Conley, Barbara A., primary, Simon, Richard M., primary, and Doroshow, James H., primary

Published
2023
Full Text
View/download PDF

36. Supplementary Data from Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131)

Author

Johnson, Douglas B., primary, Zhao, Fengmin, primary, Noel, Marcus, primary, Riely, Gregory J., primary, Mitchell, Edith P., primary, Wright, John J., primary, Chen, Helen X., primary, Gray, Robert J., primary, Li, Shuli, primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David, primary, Williams, P. Mickey, primary, Hamilton, Stanly R., primary, Conley, Barbara A., primary, Arteaga, Carlos L., primary, Harris, Lyndsay N., primary, O'Dwyer, Peter J., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2023
Full Text
View/download PDF

37. Data from Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer

Author

Kummar, Shivaani, primary, Oza, Amit M., primary, Fleming, Gini F., primary, Sullivan, Daniel M., primary, Gandara, David R., primary, Naughton, Michael J., primary, Villalona-Calero, Miguel A., primary, Morgan, Robert J., primary, Szabo, Peter M., primary, Youn, Ahrim, primary, Chen, Alice P., primary, Ji, Jiuping, primary, Allen, Deborah E., primary, Lih, Chih-Jian, primary, Mehaffey, Michele G., primary, Walsh, William D., primary, McGregor, Paul M., primary, Steinberg, Seth M., primary, Williams, P. Mickey, primary, Kinders, Robert J., primary, Conley, Barbara A., primary, Simon, Richard M., primary, and Doroshow, James H., primary

Published
2023
Full Text
View/download PDF

38. Supplementary Table 2 from A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Author

Czuczman, Myron S., primary, Trněný, Marek, primary, Davies, Andrew, primary, Rule, Simon, primary, Linton, Kim M., primary, Wagner-Johnston, Nina, primary, Gascoyne, Randy D., primary, Slack, Graham W., primary, Brousset, Pierre, primary, Eberhard, David A., primary, Hernandez-Ilizaliturri, Francisco J., primary, Salles, Gilles, primary, Witzig, Thomas E., primary, Zinzani, Pier Luigi, primary, Wright, George W., primary, Staudt, Louis M., primary, Yang, Yandan, primary, Williams, P. Mickey, primary, Lih, Chih-Jian, primary, Russo, Jacqueline, primary, Thakurta, Anjan, primary, Hagner, Patrick, primary, Fustier, Pierre, primary, Song, Dale, primary, and Lewis, Ian D., primary

Published
2023
Full Text
View/download PDF

39. Supplementary Legend from Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131)

Author

Johnson, Douglas B., primary, Zhao, Fengmin, primary, Noel, Marcus, primary, Riely, Gregory J., primary, Mitchell, Edith P., primary, Wright, John J., primary, Chen, Helen X., primary, Gray, Robert J., primary, Li, Shuli, primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David, primary, Williams, P. Mickey, primary, Hamilton, Stanly R., primary, Conley, Barbara A., primary, Arteaga, Carlos L., primary, Harris, Lyndsay N., primary, O'Dwyer, Peter J., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2023
Full Text
View/download PDF

40. Supplementary Methods, Tables S1 and S2, Figure Legend from Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer

Author

Kummar, Shivaani, primary, Oza, Amit M., primary, Fleming, Gini F., primary, Sullivan, Daniel M., primary, Gandara, David R., primary, Naughton, Michael J., primary, Villalona-Calero, Miguel A., primary, Morgan, Robert J., primary, Szabo, Peter M., primary, Youn, Ahrim, primary, Chen, Alice P., primary, Ji, Jiuping, primary, Allen, Deborah E., primary, Lih, Chih-Jian, primary, Mehaffey, Michele G., primary, Walsh, William D., primary, McGregor, Paul M., primary, Steinberg, Seth M., primary, Williams, P. Mickey, primary, Kinders, Robert J., primary, Conley, Barbara A., primary, Simon, Richard M., primary, and Doroshow, James H., primary

Published
2023
Full Text
View/download PDF

41. Figure S2 from Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer

Author

Kummar, Shivaani, primary, Oza, Amit M., primary, Fleming, Gini F., primary, Sullivan, Daniel M., primary, Gandara, David R., primary, Naughton, Michael J., primary, Villalona-Calero, Miguel A., primary, Morgan, Robert J., primary, Szabo, Peter M., primary, Youn, Ahrim, primary, Chen, Alice P., primary, Ji, Jiuping, primary, Allen, Deborah E., primary, Lih, Chih-Jian, primary, Mehaffey, Michele G., primary, Walsh, William D., primary, McGregor, Paul M., primary, Steinberg, Seth M., primary, Williams, P. Mickey, primary, Kinders, Robert J., primary, Conley, Barbara A., primary, Simon, Richard M., primary, and Doroshow, James H., primary

Published
2023
Full Text
View/download PDF

42. Supplemental Table from Differential Outcomes in Codon 12/13 and Codon 61 NRAS-Mutated Cancers in the Phase II NCI-MATCH Trial of Binimetinib in Patients with NRAS-Mutated Tumors

Author

Cleary, James M., primary, Wang, Victoria, primary, Heist, Rebecca S., primary, Kopetz, E. Scott, primary, Mitchell, Edith P., primary, Zwiebel, James A., primary, Kapner, Kevin S., primary, Chen, Helen X., primary, Li, Shuli, primary, Gray, Robert J., primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David R., primary, Meric-Bernstam, Funda, primary, Dillmon, Melissa S., primary, Williams, P. Mickey, primary, Hamilton, Stanley R., primary, Conley, Barbara A., primary, Aguirre, Andrew J., primary, O'Dwyer, Peter J., primary, Harris, Lyndsay N., primary, Arteaga, Carlos L., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2023
Full Text
View/download PDF

43. Supplementary Figure 1 from A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Author

Czuczman, Myron S., primary, Trněný, Marek, primary, Davies, Andrew, primary, Rule, Simon, primary, Linton, Kim M., primary, Wagner-Johnston, Nina, primary, Gascoyne, Randy D., primary, Slack, Graham W., primary, Brousset, Pierre, primary, Eberhard, David A., primary, Hernandez-Ilizaliturri, Francisco J., primary, Salles, Gilles, primary, Witzig, Thomas E., primary, Zinzani, Pier Luigi, primary, Wright, George W., primary, Staudt, Louis M., primary, Yang, Yandan, primary, Williams, P. Mickey, primary, Lih, Chih-Jian, primary, Russo, Jacqueline, primary, Thakurta, Anjan, primary, Hagner, Patrick, primary, Fustier, Pierre, primary, Song, Dale, primary, and Lewis, Ian D., primary

Published
2023
Full Text
View/download PDF

44. Figure S1 from Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer

Author

Kummar, Shivaani, primary, Oza, Amit M., primary, Fleming, Gini F., primary, Sullivan, Daniel M., primary, Gandara, David R., primary, Naughton, Michael J., primary, Villalona-Calero, Miguel A., primary, Morgan, Robert J., primary, Szabo, Peter M., primary, Youn, Ahrim, primary, Chen, Alice P., primary, Ji, Jiuping, primary, Allen, Deborah E., primary, Lih, Chih-Jian, primary, Mehaffey, Michele G., primary, Walsh, William D., primary, McGregor, Paul M., primary, Steinberg, Seth M., primary, Williams, P. Mickey, primary, Kinders, Robert J., primary, Conley, Barbara A., primary, Simon, Richard M., primary, and Doroshow, James H., primary

Published
2023
Full Text
View/download PDF

45. Supplementary Table 3 from A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Author

Czuczman, Myron S., primary, Trněný, Marek, primary, Davies, Andrew, primary, Rule, Simon, primary, Linton, Kim M., primary, Wagner-Johnston, Nina, primary, Gascoyne, Randy D., primary, Slack, Graham W., primary, Brousset, Pierre, primary, Eberhard, David A., primary, Hernandez-Ilizaliturri, Francisco J., primary, Salles, Gilles, primary, Witzig, Thomas E., primary, Zinzani, Pier Luigi, primary, Wright, George W., primary, Staudt, Louis M., primary, Yang, Yandan, primary, Williams, P. Mickey, primary, Lih, Chih-Jian, primary, Russo, Jacqueline, primary, Thakurta, Anjan, primary, Hagner, Patrick, primary, Fustier, Pierre, primary, Song, Dale, primary, and Lewis, Ian D., primary

Published
2023
Full Text
View/download PDF

46. Data from Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer

Author

Kummar, Shivaani, primary, Oza, Amit M., primary, Fleming, Gini F., primary, Sullivan, Daniel M., primary, Gandara, David R., primary, Naughton, Michael J., primary, Villalona-Calero, Miguel A., primary, Morgan, Robert J., primary, Szabo, Peter M., primary, Youn, Ahrim, primary, Chen, Alice P., primary, Ji, Jiuping, primary, Allen, Deborah E., primary, Lih, Chih-Jian, primary, Mehaffey, Michele G., primary, Walsh, William D., primary, McGregor, Paul M., primary, Steinberg, Seth M., primary, Williams, P. Mickey, primary, Kinders, Robert J., primary, Conley, Barbara A., primary, Simon, Richard M., primary, and Doroshow, James H., primary

Published
2023
Full Text
View/download PDF

47. Supplementary Data from Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131)

Author

Johnson, Douglas B., primary, Zhao, Fengmin, primary, Noel, Marcus, primary, Riely, Gregory J., primary, Mitchell, Edith P., primary, Wright, John J., primary, Chen, Helen X., primary, Gray, Robert J., primary, Li, Shuli, primary, McShane, Lisa M., primary, Rubinstein, Larry V., primary, Patton, David, primary, Williams, P. Mickey, primary, Hamilton, Stanly R., primary, Conley, Barbara A., primary, Arteaga, Carlos L., primary, Harris, Lyndsay N., primary, O'Dwyer, Peter J., primary, Chen, Alice P., primary, and Flaherty, Keith T., primary

Published
2023
Full Text
View/download PDF

48. Supplementary Expression Data from Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer

Author

Kummar, Shivaani, primary, Oza, Amit M., primary, Fleming, Gini F., primary, Sullivan, Daniel M., primary, Gandara, David R., primary, Naughton, Michael J., primary, Villalona-Calero, Miguel A., primary, Morgan, Robert J., primary, Szabo, Peter M., primary, Youn, Ahrim, primary, Chen, Alice P., primary, Ji, Jiuping, primary, Allen, Deborah E., primary, Lih, Chih-Jian, primary, Mehaffey, Michele G., primary, Walsh, William D., primary, McGregor, Paul M., primary, Steinberg, Seth M., primary, Williams, P. Mickey, primary, Kinders, Robert J., primary, Conley, Barbara A., primary, Simon, Richard M., primary, and Doroshow, James H., primary

Published
2023
Full Text
View/download PDF

49. Phase II Study of Palbociclib (PD-0332991) inCCND1,2, or3Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B

Author

Clark, Amy S., primary, Hong, Fangxin, additional, Finn, Richard S., additional, DeMichele, Angela M., additional, Mitchell, Edith P., additional, Zwiebel, James, additional, Arnaldez, Fernanda I., additional, Gray, Robert J., additional, Wang, Victoria, additional, McShane, Lisa M., additional, Rubinstein, Larry V., additional, Patton, David, additional, Williams, P. Mickey, additional, Hamilton, Stanley R., additional, Copur, Mehmet S., additional, Kasbari, Samer S., additional, Thind, Ravneet, additional, Conley, Barbara A., additional, Arteaga, Carlos L., additional, O'Dwyer, Peter J., additional, Harris, Lyndsay N., additional, Chen, Alice P., additional, and Flaherty, Keith T., additional

Published
2023
Full Text
View/download PDF

50. Abstract 80: Genomic characterization of PDX models from rare cancer patients in the NCI Patient-Derived Models Repository

Author

Chen, Li, primary, Pauly, Rini, additional, Chang, Ting-Chia, additional, Das, Biswajit, additional, Evrard, Yvonne A., additional, Karlovich, Chris A., additional, Vilimas, Tomas, additional, Chapman, Alyssa, additional, Nair, Nikitha, additional, Romero, Luis, additional, Fong, Anna Lee, additional, Peach, Amanda, additional, Jiwani, Shahanawaz, additional, Neishaboori, Nastaran, additional, Dutko, Lindsay, additional, Benauer, Kelly, additional, Rivera, Gloryvee, additional, Cantu, Erin, additional, Camalier, Corinne, additional, Forbes, Thomas, additional, Gottholm-Ahalt, Michelle, additional, Carter, John, additional, Borgel, Suzanne, additional, McGlynn, Chelsea, additional, Mallow, Candace, additional, Delaney, Emily, additional, Miner, Tiffanie, additional, Eugeni, Michelle A., additional, Newton, Dianne, additional, Hollingshead, Melinda G., additional, Williams, P. Mickey, additional, and Doroshow, James H., additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results